Industry
Medical - Devices
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Happy Mohamed
June 29, 2023 | 4:17 pm
Portfolio Pulse from Benzinga Insights
June 28, 2023 | 4:00 pm
Portfolio Pulse from richadhand@benzinga.com
June 28, 2023 | 2:09 pm
Portfolio Pulse from Lisa Levin
June 15, 2023 | 12:26 pm
Portfolio Pulse from Benzinga Newsdesk
June 14, 2023 | 5:02 pm
Portfolio Pulse from Benzinga Newsdesk
June 14, 2023 | 3:56 pm
Portfolio Pulse from Benzinga Insights
May 31, 2023 | 8:01 pm
Portfolio Pulse from Benzinga Newsdesk
May 31, 2023 | 11:41 am
Portfolio Pulse from Benzinga Newsdesk
May 23, 2023 | 7:07 pm
Portfolio Pulse from Benzinga Newsdesk
May 18, 2023 | 2:24 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.